Come up with a name for your new list and we'll add to it:
CNSDose raised a round of funding on November 21, 2017. Investors include
Texas Medical Center Venture Fund.
CNSDose seeks to refine how antidepressants are prescribed to individual patients through the use of a genomic test.…